On the back of growth in domestic and emerging markets formulations businesses, Zydus Lifesciences Ltd. posted a net profit of Rs 397.4 crore for the fourth quarter ended March 31, 2022 of financial year 2021-22 (FY22).
The pharma major had reported a net profit of Rs 679 crore for the fourth quarter ended March 31, 2021 of the previous financial year 2020-21 (FY21). However, when adjusted for one-time inventory provision, exceptional and non-recurring items as well as profit from discontinued operations, the net profit for Q4 of FY21 stood at Rs 525 crore.
Revenue from operations for the quarter grew